Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna : U.S. has administered 309.3 mln doses of COVID-19 vaccines, CDC says

06/13/2021 | 04:27pm EDT

June 13 (Reuters) - The United States had administered 309,322,545 doses of COVID-19 vaccines and distributed 374,398,105 doses in the country as of Sunday morning, the U.S. Centers for Disease Control and Prevention said.

Those figures were up from the 308,112,728 doses of vaccine that the CDC said had been administered as of Saturday, out of 374,397,205 doses delivered.

The agency said 173,840,483 people in the United States had received at least one dose of a vaccine, while 143,921,222 people were fully vaccinated as of 6 a.m. EDT on Sunday.

The CDC tally includes the two-dose vaccines from Moderna Inc and Pfizer Inc/BioNTech/ as well as Johnson & Johnson's one-shot vaccine. (Reporting by Maria Ponnezhath in Bengaluru; Editing by Peter Cooney)


ę Reuters 2021
All news about MODERNA, INC.
11:32aMODERNA : EMA - Increased manufacturing capacity and supply for Spikevax
AQ
11:26aGlobal markets live: Square, Pfizer, Zoom, HSBC, Ferrari
11:11aFancy a Covid jab? Here are all the free walk-in sites open in London
AQ
09:23aMODERNA : Doses First Patient in Study of IL-2 mRNA Therapeutic; Shares Rise Pre..
MT
09:22aAUTOLUS THERAPEUTICS : Grants Moderna Exclusive License to Develop mRNA Therapeu..
MT
09:12aWall Street Set for Gains, Infrastructure Bill in Focus
MT
08:45aMODERNA : Announces First Participant Dosed in Phase 1 Study of Its IL-2 mRNA Th..
BU
08:13aTop Premarket Gainers
MT
07:55aWALL STREET STOCK EXCHANGE : US stocks continue to outperform their internationa..
06:06aMODERNA : Covid-19 - US Government Provides Tunisia With One Million Doses of Mo..
AQ
More news
Financials (USD)
Sales 2021 19 103 M - -
Net income 2021 10 725 M - -
Net cash 2021 11 948 M - -
P/E ratio 2021 14,0x
Yield 2021 -
Capitalization 142 B 142 B -
EV / Sales 2021 6,81x
EV / Sales 2022 7,64x
Nbr of Employees 1 300
Free-Float 90,3%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Last Close Price 353,60 $
Average target price 187,73 $
Spread / Average Target -46,9%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.238.47%141 980
LONZA GROUP AG23.98%57 809
IQVIA HOLDINGS INC.38.25%47 462
CELLTRION, INC.-29.39%30 059
SEAGEN INC.-12.42%27 907
CUREVAC N.V.-39.24%21 497